← Leaderboards

Klaus F. Ley

Augusta University

Google Scholar ↗PubMed ↗ORCID ↗

$33,924,298

Attributed

$36,925,987

Total exposure

24

Grants

18

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.3M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$36,925,987 · 24

By mechanism

R01$16,625,758 · 8

P01$13,763,358 · 11

R35$5,942,960 · 1

S10$566,306 · 1

M01$15,105 · 2

R13$12,500 · 1

Top collaborators

Most similar at Augusta University

Same institution · by research overlap

Catherine C Hedrick$30,726,545

Others in their field

Top investigators on “Cells”

Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
Barton F Haynes · Duke University$457,457,619
David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
Dennis R. Burton · Scripps Research Institute$278,781,854
Mary M Horowitz · Medical College Of Wisconsin$237,383,608

Research focus

CellsInflammationLeukocytesAtherosclerosisMacrophageMonocyteFlow CytometryBaseInflammatoryPhenotypeIn VivoT-LymphocyteApolipoprotein ECd4 Positive T LymphocytesProteinsCytokineIntravital MicroscopyAortaImmuneGenesMouse ModelArteriesApolipoproteins BAntibodies

Grant awards (92)

Vascular macrophages and T cells in atherosclerosis$769,886

R35 · FY2025 · HL · contact PI

Vascular macrophages and T cells in atherosclerosis$754,375

R35 · FY2024 · HL · contact PI

Mechanism of kindlin-3-dependent integrin activation$541,420

P01 · FY2024 · HL · contact PI

Vascular macrophages and T cells in atherosclerosis$769,654

R35 · FY2023 · HL · contact PI

Mechanism of kindlin-3-dependent integrin activation$549,216

P01 · FY2023 · HL · contact PI

Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV$819,924

R01 · FY2022 · HL

Vascular macrophages and T cells in atherosclerosis$588,993

R35 · FY2022 · HL · contact PI

Mechanism of kindlin-3-dependent integrin activation$549,303

P01 · FY2022 · HL · contact PI

Vascular macrophages and T cells in atherosclerosis$318,324

R35 · FY2022 · HL · contact PI

Core B: Single Cell Protein and RNA Sequencing Core$53,486

P01 · FY2022 · HL · contact PI

Project 4: APOB-specific CD4 and CD8 T cells exacerbate atherosclerosis$43,008

P01 · FY2022 · HL · contact PI

Vascular macrophages and T cells in atherosclerosis$907,152

R35 · FY2021 · HL · contact PI

Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV$814,084

R01 · FY2021 · HL

Mechanism of kindlin-3-dependent integrin activation$549,277

P01 · FY2021 · HL · contact PI

Core E: Cell sorting, CyTOF and RNA-Seq$544,461

P01 · FY2021 · HL · contact PI

ApoB-specific CD4 T cells in mouse and human atherosclerosis$389,777

P01 · FY2021 · HL · contact PI

Vascular macrophages and T cells in atherosclerosis$906,991

R35 · FY2020 · HL · contact PI

Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV$843,391

R01 · FY2020 · HL

Mechanism of kindlin-3-dependent integrin activation$576,450

P01 · FY2020 · HL · contact PI

Core E: Cell sorting, CyTOF and RNA-Seq$543,785

P01 · FY2020 · HL · contact PI

ApoB-specific CD4 T cells in mouse and human atherosclerosis$389,294

P01 · FY2020 · HL · contact PI

Vascular macrophages and T cells in atherosclerosis$927,585

R35 · FY2019 · HL · contact PI

Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV$846,562

R01 · FY2019 · HL

Core E: Cell sorting, CyTOF and RNA-Seq$543,785

P01 · FY2019 · HL · contact PI

ApoB-specific CD4 T cells in mouse and human atherosclerosis$389,294

P01 · FY2019 · HL · contact PI

Core E: Cell sorting, CyTOF and RNA-Seq$543,774

P01 · FY2018 · HL · contact PI

Myeloid cell interactions in atherosclerosis$450,000

R01 · FY2018 · HL · contact PI

Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis$436,250

R01 · FY2018 · HL · contact PI

ApoB-specific CD4 T cells in mouse and human atherosclerosis$389,286

P01 · FY2018 · HL · contact PI

Cell Phenotyping Core$95,792

P01 · FY2018 · HL · contact PI

Core E: Cell sorting, CyTOF and RNA-Seq$566,941

P01 · FY2017 · HL · contact PI

Super-resolution confocal microscope$566,306

S10 · FY2017 · OD · contact PI

Myeloid cell interactions in atherosclerosis$450,000

R01 · FY2017 · HL · contact PI

Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis$436,250

R01 · FY2017 · HL · contact PI

ApoB-specific CD4 T cells in mouse and human atherosclerosis$405,872

P01 · FY2017 · HL · contact PI

Cell Phenotyping Core$95,792

P01 · FY2017 · HL · contact PI

Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis$436,250

R01 · FY2016 · HL · contact PI

Myeloid cell interactions with T cells in atherosclerosis$433,460

R01 · FY2016 · HL · contact PI

Cell Phenotyping Core$95,792

P01 · FY2016 · HL · contact PI

Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis$455,500

R01 · FY2015 · HL · contact PI

Myeloid cell interactions with T cells in atherosclerosis$426,959

R01 · FY2015 · HL · contact PI

Role of Dendritic Cells and Macrophages in Chronic Ileitis$249,351

P01 · FY2015 · DK · contact PI

Cell Phenotyping Core$94,356

P01 · FY2015 · HL · contact PI

Myeloid cell interactions with T cells in atherosclerosis$424,792

R01 · FY2014 · HL · contact PI

Role of Dendritic Cells and Macrophages in Chronic Ileitis$249,479

P01 · FY2014 · DK · contact PI

Cell Phenotyping Core$109,253

P01 · FY2014 · HL · contact PI

Biomarkers of Inflammation and Vaso-occlusion in Sickle Cell Disease$770,409

R01 · FY2013 · HL

Myeloid cell interactions with T cells in atherosclerosis$433,034

R01 · FY2013 · HL · contact PI

Role of Dendritic Cells and Macrophages in Chronic Ileitis$239,020

P01 · FY2013 · DK · contact PI

VASCULATA 2013: Vascular Immunology$12,500

R13 · FY2013 · HL · contact PI

Biomarkers of Inflammation and Vaso-occlusion in Sickle Cell Disease$904,227

R01 · FY2012 · HL

Myeloid cell interactions with T cells in atherosclerosis$566,124

R01 · FY2012 · HL · contact PI

Role of Dendritic Cells and Macrophages in Chronic Ileitis$249,722

P01 · FY2012 · DK · contact PI

Role of Dendritic Cells and Macrophages in Chronic Ileitis$350,395

P01 · FY2011 · DK · contact PI

GLUCOSE, INSULIN IN DIABETIC VASCULAR DISEASE$543,171

P01 · FY2010 · HL · contact PI

GLUCOSE, INSULIN IN DIABETIC VASCULAR DISEASE$587,920

P01 · FY2009 · HL · contact PI

Monocyte Adhesion to Atheroma in Gene Targeted Mice$412,918

R01 · FY2009 · HL · contact PI

MECNHANISMS OF CELL ADHESION AND TRAFFICKING IN EXPERIMENTAL ILEITIS$198,527

P01 · FY2009 · DK · contact PI

GLUCOSE, INSULIN IN DIABETIC VASCULAR DISEASE$559,875

P01 · FY2008 · HL · contact PI

Monocyte Adhesion to Atheroma in Gene Targeted Mice$412,918

R01 · FY2008 · HL · contact PI

MECNHANISMS OF CELL ADHESION AND TRAFFICKING IN EXPERIMENTAL ILEITIS$195,504

P01 · FY2008 · DK · contact PI

FOAM CELL DIFFERENTIATION IN ATHEROSCLEROSIS$5,171

M01 · FY2008 · RR · contact PI

GLUCOSE, INSULIN IN DIABETIC VASCULAR DISEASE$366,435

P01 · FY2007 · HL · contact PI

Monocyte Adhesion to Atheroma in Gene Targeted Mice$281,590

R01 · FY2007 · HL · contact PI

MECNHANISMS OF CELL ADHESION AND TRAFFICKING IN EXPERIMENTAL ILEITIS$192,224

P01 · FY2007 · DK · contact PI

Monocyte Adhesion to Atheroma in Gene Targeted Mice$49,400

R01 · FY2007 · HL · contact PI

Biomechanics of Leukocytes and Molecular Imaging Agents$1,015,147

R01 · FY2006 · EB · contact PI

GLUCOSE, INSULIN IN DIABETIC VASCULAR DISEASE$555,225

P01 · FY2006 · HL · contact PI

Monocyte Adhesion to Atheroma in Gene Targeted Mice$341,437

R01 · FY2006 · HL · contact PI

MECNHANISMS OF CELL ADHESION AND TRAFFICKING IN EXPERIMENTAL ILEITIS$183,598

P01 · FY2006 · DK · contact PI

Monocyte Adhesion to Atheroma in Gene Targeted$222,000

R01 · FY2005 · HL

MECNHANISMS OF CELL ADHESION AND TRAFFICKING IN EXPERIMENTAL ILEITIS$179,231

P01 · FY2005 · DK

Monocyte Adhesion to Atheroma in Gene Targeted$222,000

R01 · FY2004 · HL

Rolling and adhesion of leukocytes$9,934

M01 · FY2004 · RR

BIOMECHANICS OF LEUKOCYTE ADHESION MOLECULES$631,079

R01 · FY2003 · EB

Monocyte Adhesion to Atheroma in Gene Targeted$222,000

R01 · FY2003 · HL

BIOMECHANICS OF LEUKOCYTE ADHESION MOLECULES$627,323

R01 · FY2002 · HL

Monocyte Adhesion to Atheroma in Gene Targeted Mice$222,000

R01 · FY2002 · HL

SELECTIN MEDIATED LEUKOCYTE ADHESION IN VIVO$190,953

R01 · FY2002 · HL

CELL ADHESION &TRAFFICKING IN EXPERIMENTAL ILEITIS$107,756

P01 · FY2002 · DK

CELL ADHESION &TRAFFICKING IN EXPERIMENTAL ILEITIS$107,756

P01 · FY2002 · DK

Monocyte adhesion to atherosclerotic lesions in diabetes$0

P01 · FY2002 · HL

BIOMECHANICS OF LEUKOCYTE ADHESION MOLECULES$612,626

R01 · FY2001 · HL

SELECTIN MEDIATED LEUKOCYTE ADHESION IN VIVO$185,443

R01 · FY2001 · HL

CELL ADHESION &TRAFFICKING IN EXPERIMENTAL ILEITIS$160,333

P01 · FY2001 · DK

CELL ADHESION &TRAFFICKING IN EXPERIMENTAL ILEITIS$160,333

P01 · FY2001 · DK

CELL ADHESION &TRAFFICKING IN EXPERIMENTAL ILEITIS$107,756

P01 · FY2001 · DK

Monocyte adhesion to atherosclerotic lesions in diabetes$0

P01 · FY2001 · HL

BIOMECHANICS OF LEUKOCYTE ADHESION MOLECULES$598,359

R01 · FY2000 · HL

MONOCYTE ADHESION TO ATHEROMA IN GENE TARGETED MICE$251,256

R01 · FY2000 · HL

SELECTIN MEDIATED LEUKOCYTE ADHESION IN VIVO$180,093

R01 · FY2000 · HL

CELL ADHESION &TRAFFICKING IN EXPERIMENTAL ILEITIS$160,333

P01 · FY2000 · DK